Comparison of Nasal Continuous Positive Airway Pressure (CPAP) Mask and Nasal Airway in Molar Tooth Extraction Under Deep Sedation
Launched by GÖZDE NUR ERKAN · May 28, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of two different types of breathing support—either a nasal Continuous Positive Airway Pressure (CPAP) mask or a nasal airway—during deep sedation for patients having impacted molars removed. The goal is to find out which method provides better comfort and safety during and after the dental procedure, as well as to see how satisfied both patients and dentists are with the different options.
To participate in this study, you should be an adult between 18 and 60 years old, scheduled for tooth extraction that will take between 20 and 60 minutes. You should be generally healthy with a body mass index (BMI) of 30 or less. If you meet these criteria, you can expect to be randomly assigned to one of the two breathing support methods. The study aims to make dental procedures under sedation safer and more comfortable, especially for those who may have fears or anxieties about dental work. Your participation could help improve future dental care for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteer adult patients aged 18-60 years
- • Patients scheduled for impacted tooth extraction
- • Cases with surgical time ≥20 minutes and ≤60 minutes
- • American Society of Anaesthesiologists (ASA) physical status I and II patients
- • Patients with BMI≤30
- Exclusion Criteria:
- • Patients under 18 years old-over 60 years old
- • Surgeries with a procedure time over 1 hour or less than 20 minutes
- • American Society of Anaesthesiologists (ASA) physical status III and higher patients
- • Presence of conditions such as mental retardation that impair the patient's ability to make decisions about himself/herself
- • Patients with respiratory system diseases such as asthma, chronic obstructive pulmonary disease (COPD) or airway hyperreactivity
- • Patients with a condition that severely narrows the nasal passage opening (e.g. adenoid hypertrophy, etc.)
- • Patients with BMI\>30
- • Patients who refused to participate in the study
About Gözde Nur Erkan
Gözde Nur Erkan is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical standards and regulatory compliance, Gözde Nur Erkan collaborates with healthcare professionals and research institutions to facilitate the development of cutting-edge therapies across various therapeutic areas. By prioritizing patient safety and fostering transparent communication, the organization aims to contribute significantly to the scientific community and enhance the quality of care in clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kayseri, , Turkey
Kırıkkale, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0